Novi GLP-1 Review 2026: Compounded Semaglutide & Tirzepatide — Cost, Safety, and What You Need to Know
Published: May 26, 2026 · By ExploreTreatments Editorial Team · 8 min read
If Novi keeps appearing in your search results for GLP-1 telehealth programs, you are far from alone. The compounded GLP-1 space has expanded rapidly, and with it has come a flood of questions from people trying to separate accurate information from marketing noise. This review addresses those questions directly — covering how the program works, what the current regulatory environment means for compounded medications, what the fine print actually says, and who this type of program may or may not suit.
Quick-Look Summary: Novi GLP-1 at a Glance
| Provider | Novi International LLC |
|---|---|
| Program Type | Telehealth GLP-1 weight loss platform |
| Compounded Semaglutide | From $133/month (promotional pricing as of April 2026) |
| Compounded Tirzepatide | From $166/month |
| Medications | Compounded — not FDA-approved finished products |
| Prescription Required | Yes — by independent licensed U.S. clinicians |
| Delivery | Free 2-day shipping |
| Insurance | Cash-pay only |
| Cancellation | FAQ says month-to-month; ToS says 3-month minimum — verify before enrolling |
| Refunds | No returns once prescription dispensed or shipped |
| Support | 7 days/week; unlimited clinician check-ins per company |
Compounded GLP-1 Medications: What You Must Understand First
This section appears before pricing and enrollment steps — intentionally. It is the most important part of this review.
The FDA resolved the tirzepatide shortage in December 2024 and the semaglutide shortage in February 2025. Since then, enforcement has tightened significantly. In February 2026, the FDA announced plans to restrict ingredients used in mass-marketed compounded GLP-1 drugs. As recently as April 2026, the FDA issued further reminders to compounding pharmacies about the legal limits of their exemptions.
The FDA has explicitly stated that marketers cannot claim compounded GLP-1s are generic, equivalent to, or produce identical outcomes as FDA-approved drugs. This applies to every telehealth platform offering compounded GLP-1 medications in 2026 — not just Novi.
Consult a qualified healthcare professional before starting any weight-loss program or prescription treatment.
How Novi Works: The Three-Entity Structure
Understanding who does what inside a telehealth GLP-1 program matters more than most marketing pages suggest. Novi operates through a three-entity structure common in this space — and those distinctions carry real implications for your care.
- 1.Novi International LLC — The Platform Layer
Handles intake, billing, and coordination. Per its own Terms of Service, Novi is not a healthcare provider and does not provide medical advice.
- 2.Licensed Clinicians — The Prescribing Layer
Independent board-certified physicians and nurse practitioners who review your health information and make prescribing decisions. The platform cannot guarantee a prescription.
- 3.Partner Pharmacies — The Fulfillment Layer
Licensed U.S. pharmacies that compound and dispense medication. Separate from both the platform and the clinicians.
What Novi Says Is Included
According to the company's website, eligible patients receive a 4-week supply delivered monthly, administration supplies, unlimited clinician check-ins and dose adjustment support, and coaching — all described as part of the monthly price with no hidden fees.
Included Per Company
- ✓4-week medication supply delivered monthly
- ✓Administration supplies (injection materials)
- ✓Unlimited clinician check-ins and dose adjustment
- ✓Coaching support included in monthly price
- ✓Free 2-day shipping
Platform Convenience
- ✓100% online — no in-person visits required
- ✓Pre-approval quiz takes approximately 3 minutes
- ✓Licensed U.S.-based clinicians review your intake
- ✓Support available 7 days a week
- ✓Named, board-certified clinical team on website
Novi Pricing: Current Costs as of April 2026
Pricing is one of the most-asked-about aspects of the program. Below is what the company's promotional page listed as of April 2026:
| Compounded Semaglutide | From $133/month — reflects a $200 promotional discount. Not FDA-approved finished product. |
|---|---|
| Compounded Tirzepatide | From $166/month — dual GLP-1/GIP action. Not FDA-approved finished product. |
| Insurance | Cash-pay only. No insurance accepted. HSA/FSA may apply — verify with your plan. |
| Shipping | Free 2-day. Included with prescription when fulfilled. |
The FAQ vs. Terms of Service Conflict: Read Before You Enroll
This is one of the most practically important issues in this review. Novi's FAQ and Terms of Service present materially different language on commitment and cancellation.
What the FAQ Says
"You can cancel your Novi subscription at any time. Our program is month-to-month with no minimum commitments or long-term contracts, so cancellation is simple and flexible."
What the Terms of Service Say
"Subscription based Products and/or Services require a minimum 3-month commitment… By enrolling in Subscription Services, you agree to pay for a minimum of three (3) consecutive months."
The Terms also state: "False credit card disputes will be aggressively defended and customers who attempt to dispute charges to circumvent the 3-month commitment will be sent to collections and/or have further legal action pursued."
The governing Terms of Service — not the FAQ — typically control the legal relationship. Review both documents and contact Novi's support team for written clarification before committing any payment.
Additionally, once a prescription is dispensed or shipped, the company states it cannot be returned or refunded. Combined with the 3-month commitment language, your total financial obligation after enrolling may be considerably larger than the FAQ framing initially suggests.
Novi's Named Clinical Team — A Transparency Advantage
According to the company's website, Novi's clinical team includes named, board-certified providers — a transparency element not all telehealth platforms offer. Note that the specific clinician who reviews your intake may or may not be one of the providers featured on the website.
| Daniel Funsch, MD | American Board of Emergency Medicine |
|---|---|
| Michael Wasef, MD | American Board of Internal Medicine |
| Takashi Nakamura, MD | American Board of Emergency Medicine |
| Kimberli Hastings, NP | American Academy of Nurse Practitioners |
| Kristine Clements, NP | Board-certified FNP, 25+ years experience, USAF flight medic |
| Theresa Vergara, NP | Certified NP with Doctorate in Nursing |
GLP-1 Clinical Context: What Published Research Shows
Published clinical studies on FDA-approved semaglutide and tirzepatide explain why GLP-1 medications have attracted significant clinical interest. These results are included for educational context only and do not establish equivalent outcomes for compounded formulations or any telehealth program.
Semaglutide — STEP 1 Trial
Mean weight reduction of approximately 14.9% over 68 weeks with FDA-approved 2.4 mg semaglutide vs. 2.4% placebo. Over 86% of participants achieved at least 5% weight loss. Across the STEP program, results ranged from approximately 14.9% to 17.4%.
Tirzepatide — SURMOUNT-1 Trial
Mean weight reduction of approximately 22.5% at the 15 mg dose over 72 weeks. Approximately 63% achieved 20%+ weight loss at the highest dose. The SURMOUNT-5 head-to-head found tirzepatide outperformed semaglutide (20.2% vs. 13.7%).
Novi vs. Traditional Weight Loss: Who Should Consider Novi?
Based on what the company publicly discloses, Novi may fit well for some patients and not at all for others:
| Factor | Novi GLP-1 | Traditional In-Person |
|---|---|---|
| Consultation Type | 100% Online | In-office visit |
| Medication Type | Compounded (not FDA-approved) | FDA-approved brand options |
| Starting Cost | From $133/mo | Varies widely |
| Insurance | Cash-pay only | May be covered |
| Delivery | Free 2-day home delivery | Pharmacy pickup |
| Clinical Support | 7 days/week | Office hours |
Novi GLP-1: Frequently Asked Questions
Contact Novi Directly
| support@joinnovi.com | |
| Phone | 214-427-4553 |
| Support Hours | 7 days a week |
| Mailing | Novi International LLC, 30 N Gould St Ste R, Sheridan, WY 82801 |
Novi GLP-1 Review Summary: The Bottom Line
Our Editorial Take
Novi's telehealth GLP-1 program offers a cash-pay pathway to compounded semaglutide and tirzepatide through licensed clinicians and U.S. pharmacies. Based on its publicly displayed pricing at the time of publication, it represents a lower-priced entry point in the compounded GLP-1 space. Cost is only one factor — the regulatory distinction between compounded and FDA-approved products, the rapidly evolving FDA enforcement landscape, and the discrepancy between the company's FAQ and Terms of Service all belong in your decision-making process.
Novi distinguishes itself with its $133/month entry point and named clinical team. The pricing transparency is genuinely useful. That said, like all compounded GLP-1 programs, the value depends entirely on the quality of clinical oversight — ask specifically about follow-up frequency and what "ongoing support" includes before committing.
Advertising & Affiliate Disclosure: We may receive compensation when you click on links to partners featured on this site. Our rankings and recommendations are based on our independent research methodology and editorial standards, not on sponsorship or payment. Some links are affiliate links, which means we may earn a commission at no extra cost to you if you make a purchase.
Medical Disclaimer: The content on this site is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider for medical questions, treatment decisions, or emergency care. Do not disregard professional medical advice or delay seeking it based on information found here.